CIK: 0001557543
Total reported value
$468.9M
Reporting period: 2017-09-30 · Number of holdings: 13
NORTH TIDE CAPITAL, LLC disclosed 13 holdings in its latest 13F filing for the period ending 2017-09-30, with total reported value of $468.9M and a quarterly turnover rate of 75.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "N"
North Tide Capital, LLC's disclosed holdings carry a Herfindahl concentration index of 0.106 — mathematically equivalent to about 9 equally-sized positions, close to its 13 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.64), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 34% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim HWAYEUR
-70.0% -$69.0M
Add MCK
+233.3% $52.1M
Trim GILD
-50.0% -$30.3M
Add SEM
-10.0% $9.7M
Add THC
+53.4% $5.9M
Add N59465109
+35.0% $3.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SEM | Select Medical Holdings CORP | Stock-Other | 18.43% | +1.35% | -10.00% | |
| 2 | MCK | Mckesson CORP | Stock-Healthcare | 16.38% | +10.89% | +233.33% | |
| 3 | ✓ | Supervalu Inc | Stock-Other | 9.28% | +9.28% | NEW | |
| 4 | ✓ | Mylan N V | Stock-Other | 9.03% | +0.39% | +35.00% | |
| 5 | GILD | Gilead Sciences INC | Stock-Healthcare | 8.64% | -7.11% | -50.00% | |
| 6 | ✓ | Stock-Other | 7.31% | -0.15% | +33.33% | ||
| 7 | HWAYEUR | Tivity Health INC | Stock-Other | 6.53% | -15.64% | -70.00% | |
| 8 | PRGO | Perrigo Company plc | Stock-Healthcare | 5.42% | +0.38% | — | |
| 9 | THC | Tenet Healthcare CORP | Stock-Healthcare | 5.38% | +1.08% | +53.42% | |
| 10 | AXP | American Express Company | Stock-Financials | 4.73% | +4.73% | NEW | |
| 11 | CVS | Cvs Health CORP | Stock-Healthcare | 4.34% | +4.34% | NEW | |
| 12 | IVCUSD | Invacare CORP | Stock-Other | 3.44% | +3.44% | NEW | |
| 13 | PACB | Pacific Biosciences Of Calif | Stock-Other | 1.12% | +1.12% | NEW |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2017-09-30 | 13 | $468.9M | 75 | |
| 2017-06-30 | 12 | $449.4M | 58 | |
| 2017-03-31 | 16 | $650.7M | 100 | |
| 2016-12-31 | 15 | $584.9M | 60 | |
| 2016-09-30 | 17 | $918.6M | 56 | |
| 2016-06-30 | 18 | $897.4M | 58 | |
| 2016-03-31 | 15 | $924.3M | 35 | |
| 2015-12-31 | 14 | $1.0B | 51 | |
| 2015-09-30 | 16 | $1.1B | 48 | |
| 2015-06-30 | 22 | $1.4B | 59 | |
| 2015-03-31 | 20 | $1.3B | 60 | |
| 2014-12-31 | 25 | $1.5B | 35 | |
| 2014-09-30 | 25 | $1.3B | 56 | |
| 2014-06-30 | 26 | $1.4B | 51 | |
| 2014-03-31 | 24 | $1.2B | 54 | |
| 2013-12-31 | 28 | $1.1B | 56 | |
| 2013-09-30 | 27 | $953.3M | 64 | |
| 2013-06-30 | 23 | $564.3M | 0 |
North Tide Capital, LLC's most significant position changes for 2017-09-30: New buy: Supervalu Inc; Sold out: Supervalu INC; New buy: American Express Company (AXP); New buy: Cvs Health CORP (CVS); New buy: Invacare CORP (IVCUSD).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MCK | Mckesson CORP | +10.9% | +233.33% | Add |
| 2 | SEM | Select Medical Holdings CORP | +1.4% | -10.00% | Trim |
| 3 | THC | Tenet Healthcare CORP | +1.1% | +53.42% | Add |
| 4 | ✓ | Mylan N V | +0.4% | +35.00% | Add |
| 5 | PRGO | Perrigo Company plc | +0.4% | — | Unchanged |
| 6 | ✓ | -0.2% | +33.33% | Add | |
| 7 | GILD | Gilead Sciences INC | -7.1% | -50.00% | Trim |
| 8 | HWAYEUR | Tivity Health INC | -15.6% | -70.00% | Trim |
| 9 | ✓ | Supervalu Inc | — | NEW | New buy |
| 10 | ✓ | Supervalu INC | — | EXIT | Sold out |
| 11 | AXP | American Express Company | — | NEW | New buy |
| 12 | CVS | Cvs Health CORP | — | NEW | New buy |
| 13 | IVCUSD | Invacare CORP | — | NEW | New buy |
| 14 | IPXLEUR | Impax Laboratories INC | — | EXIT | Sold out |
| 15 | BIOSEUR | Bioscrip INC | — | EXIT | Sold out |
| 16 | ✓ | Vivus INC | — | EXIT | Sold out |
| 17 | PACB | Pacific Biosciences Of Calif | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-13 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001678378
Total reported value
$468.9M
6 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002020935
Total reported value
$469.0M
36 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001803804
Total reported value
$469.2M
1,248 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
1 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0000045319
Total reported value
$3.2B
270 stks
2026-03-31
1 of the top 5 holdings overlap, including Mckesson CORP
CIK 0000275216
Total reported value
$11.6B
1,648 stks
2015-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Gilead Sciences INC